Potential conflict of interest: Nothing to report.
Steatohepatitis/Metabolic Liver Disease
Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow–derived cells
Article first published online: 1 APR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1816–1829, May 2014
How to Cite
Nagaishi, K., Ataka, K., Echizen, E., Arimura, Y. and Fujimiya, M. (2014), Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow–derived cells. Hepatology, 59: 1816–1829. doi: 10.1002/hep.26975
This work was supported, in part, by a Grant-in-Aid for Scientific Research (C) in Japan (to K.N.).
- Issue published online: 23 APR 2014
- Article first published online: 1 APR 2014
- Accepted manuscript online: 21 DEC 2013 12:22AM EST
- Manuscript Accepted: 12 DEC 2013
- Manuscript Received: 13 JAN 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.